What is Cytek Biosciences, Inc.'s return on assets?

Cytek Biosciences, Inc. (CTKB) reported return on assets of -15.9% in Q1 2026.

What does return on assets mean?

Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.

Cytek Biosciences, Inc. CTKB Return on assets

Name: Cytek Biosciences, Inc. Return on assets — Quarterly & Annual Data
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Return on assets at other companies

Becton, Dickinson and CompanyBDX

2.2%-0.6pp

Thermo Fisher ScientificTMO

6.5%-0.2pp

DanaherDHR

4.5%-0.1pp

Fulgent Genetics, Inc.FLGT

-6.2%+40.5pp

10x Genomics, Inc.TXG

-2.4%-1.1pp

TEC

Bio-TechneTECH

4.9%-2.7pp

Other financials

Income statement

See full

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

See full

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

See full

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

See full

Gross margin51.7%-3.2pp

Operating margin-21.5%—

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

See full

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Calculated from Cytek Biosciences, Inc.’s reported figures.

net income/total assets=-15.9%

Based on trailing twelve months.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s return on assets?: Cytek Biosciences, Inc. (CTKB) reported return on assets of -15.9% in Q1 2026.
What does return on assets mean?: Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.